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Abstract
Background: Life expectancy has been increasing during the last century within the European Union (EU). To
measure progress in population health it is no longer sufficient to focus on the duration of life but quality of life
should be considered. Healthy Life Years (HLY) allow estimating the quality of the remaining years that a person is
expected to live, in terms of being free of long-standing activity limitation. The Joint Action on Healthy Life Years
(JA: EHLEIS) is a joint action of European Member States (MS) and the European Union aiming at analysing trends,
patterns and differences in HLY, as well as in other Summary Measures of Population Health (SMPH) indicators,
across the European member states.
Methods: The JA: EHLEIS consolidates existing information on life and health expectancy by maximising the European
comparability; by analysing trends in HLY within the EU; by analysing the evolution of the differences in HLY between
Member States; and by identifying both macro-level as micro-level determinants of the inequalities in HLY. The JA:
EHLEIS works in collaboration with the USA, Japan and OECD on the development of new SMPHs to be used globally.
To strengthen the utility of the HLY for policy-making, annual meetings with policy-makers are planned.
Results: The information system allows the estimation of a set of health indicators (morbidity and disability prevalence,
life and health expectancies) for Europe, Member States and shortly their regional levels. An annual country report on
HLY in the national languages is available. The JA: EHLEIS is developing statistical attribution and decomposition tools
which will be helpful to determine the impact of specific diseases, life styles or other determinants on differences in
HLY. Through a set of international workshops the JA: EHLEIS aims to develop a blueprint for an international
harmonized Summary Measure of Population Health.
Conclusion: The JA: EHLEIS objectives are to monitor progress towards the headline target of the Europe 2020 strategy
of increasing HLY by 2 years by 2020 and to support policy development by identifying the main determinants of
active and healthy ageing in Europe.
Keywords: Health status indicators, Gender, Socioeconomic status, Public health, Health expectancy, Healthy life years,
EU
Background
Life expectancy at birth has steadily increased during the
last decade in the EU27, by more than 3 years for men
and 2 years for women, leading to accelerated popula-
tion ageing. However gaps among Member States of the
European Union (EU) have remained large, 13 years in
both 1997 and 2010 for men, although for women gaps
have slightly reduced from more than 9 years in 1997 to
8 years in 2010. Additionally the gender gap in life
expectancy at birth remains high at 6 years in 2010
although it also has reduced over time. When the quality
of the years lived is taken into account through health
expectancies such as life expectancy in good perceived
health, life expectancy without chronic morbidity, or life
expectancy without disability, even larger gaps are seen
among European countries. For instance, life expectancy
without long-standing activity limitations or Healthy Life
Years (HLY) show gaps in both men and women reach-
ing close to 20 years in 2010 among Member States [1].
The HLY is technically a Summary Measure of Popula-
tion Health and part of the family of disability-free life
expectancy indicators which measure the number of
remaining years that a person of a certain age is expected
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to live without disability. A Summary Measure of Popula-
tion Health brings together data on both the length and
the quality of life [2] and are considered important popu-
lation health outcome measures [3]. In the HLY indicator,
disability is measured through the global activity limitation
indicator (GALI) which is a single survey question captu-
ring long-standing limitations in usual activities [4,5]. In
2005 it was included as the only Lisbon Structural Indica-
tor on health with the main purpose to monitor health
trends and health gaps in Europe [6]. The utility and rele-
vance of HLY for public health depends on a number of
issues being resolved, including: maximising the pan-
European comparability of the measure of long-standing
limitations; decomposition of the gaps in HLY by origin
(mortality or disability), or by cause of morbidity and age
group responsible; and the ability to assess the impact of
changes in health determinants and health interventions
on HLY. For instance, there is some evidence suggesting
that the effect of health determinants such as smoking
decreases the total life expectancy and decreases both the
years without and with disability, while other determinants
such as obesity decrease the years without disability but
increases the years with disability [7]. At a national and
EU level, the utility of HLY also depends on whether it
can be computed by population sub-groups (i.e. socio-
economic groups) and by sub-national units.
As measures of population health, HLY and health
expectancies in general have several strengths. Health
expectancy indicators are more intuitive and understand-
able for policy makers and the public at large compared to
mortality rates or morbidity incidence or prevalence rates.
Health expectancies are typically estimated based on
cross-sectional survey data [8] and guidelines for calcula-
tion have been made freely available [9]. However the use
of varying definitions of health, morbidity and disability
has hampered the international comparability of health
expectancy indicators and for their ability to monitor time
trends in population health. The international research
network REVES (Réseau Espérance de Vie en Santé –
International Network on Health Expectancies) was set up
in 1989 to tackle these issues and to work on definitions,
measurements and comparison of disability globally [10].
Following the Maastricht Treaty in 1993 the EU initiated
horizontal actions to develop health monitoring and
health indicators [11] including health expectancies which
were the focus of two EURO-REVES projects. A major
deliverable of the Euro-REVES projects was the develop-
ment of a coherent set of instruments to monitor health
across Europe [12] and the successful introduction of
these common instruments into several European surveys
such as the European Health Interview Survey (EHIS) and
the European Survey on Income and Living Conditions
(EU-SILC) enabled for the first time estimation of HLY in
all EU Member States in a harmonised way.
The next step in this process was to structure and
harmonize the calculation, analysis and interpretation of
data collected through those surveys. This goal was
achieved by the European Health Expectancy Monitoring
Unit (EHEMU) and the European Health and Life Expect-
ancy Information System (EHLEIS) project. EHEMU
established an information system which facilitates the cal-
culation of life and health expectancies in the EU and its
Member States. This information system provides a cen-
tral facility for the co-ordinated analysis and synthesis of
life and health expectancies and provides evidence of
inequalities between Member States, highlighting potential
targets for public health strategies both nationally and at a
pan-European level. EHLEIS extended the EHEMU acti-
vities by more in-depth analysis of trends and gender gaps
in health expectancies [13,14] and of how the similarity or
differences between groups of Member States are corre-
lated with macro level factors covering broad areas of
wealth and expenditure (GDP, poverty risk, inequality of
income distribution, expenditure on elderly care, labour
force participation (employment rate of older at age
55–64 years, long-term unemployment rate, mean exit age
from labour force), and level of education (life-long lear-
ning, low education attainment)) [15,16]. Additionally the
EHLEIS project provided training workshops to ensure
best practice and a deeper understanding of health expec-
tancy indicators, and, through regular communica-
tion, enabled policy makers, public health officials and
researchers to exchange information on the utility of the
health expectancy indicators and how they are incorpo-
rated in government strategies in the EU Member States
[17]. From 2011 onwards projects on health expectancies
are conducted within the framework of a Joint Action on
Healthy Life Years (JA: EHLEIS) among the European
Commission and the Member States.
The joint action on healthy life years
Within the programme of the Community action in the
field of health [18], JA: EHLEIS addresses the topic
“Maintain and continue developing a European Health
and Life Expectancy Information System, in order to
improve and harmonise calculations for the development
of the Healthy Life Years – HLY – structural indicator”.
Accordingly the JA: EHLEIS
(i) consolidates the existing information system
(EHLEIS) through promoting further European
comparability, annual HLY calculations and
dissemination (online information system, annual
country reports [1]) and updating of trends and gap
analysis at the EU level, as well as the role of
macro-level factors in explaining these gaps,
(ii) further extends EHLEIS through analyses of micro-
level health determinants using the new European
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Health Interview Survey (EHIS) and analyses of
HLY gaps between socio-economic groups,
(iii) develops an alternative Summary Measure of
Population Health that can also serve as a common
international measure beyond the EU,
(iv) Integrates the Task Force on Health Expectancies
[19] into an annual meeting to further engage
Member States and promote HLY use in policy-
making within Member States.
In particular, in the trend and gap analyses the
JA: EHLEIS utilises a range of health expectancies,
including self-rated health, morbidity and disability. The
JA also develops a study design for computing
maximally comparable health expectancies by socio-
economic status for the Member States that already have
mortality data by socio-economic position. Finally, in
collaboration with the main OECD countries, especially
the United States of America (USA) and Japan, the
JA: EHLEIS will provide a blue print for an improved
new internationally comparable Summary Measure of
Population Health, thus upgrading the current European
HLY by a global indicator. A Summary Measure of
Population Health that is comparable to the USA and
Japan indicators is a necessary condition to achieve a
grade “A” for European Structural Indicators. The inter-
national discussion will not focus on the health expec-
tancy indicator as such but rather on the essential of
how to measure the health or quality of life related in-
formation necessary to calculate the health expectancy.
Target groups
The JA: EHLEIS targets Member States, health and
non-health policy makers at the regional, national and
European level, health professionals and researchers,
media, general public and Non Governmental Organiza-
tions (NGO). Increasing involvement of Member States
in health monitoring is one of the main priorities of
JA: EHLEIS as well as promoting their wider engage-
ment in using HLY in policy-making. The annual public
JA: EHLEIS meeting plays a central role in addressing
these priorities. In addition, the work published by the
EHLEIS group in The Lancet in 2008 is a good example
of HLY use in non-health policies [15]. Scientific mate-
rial will be provided to the health professional and
research communities through: databases, technical
reports and scientific publications, adding to the papers
already published by EHLEIS on the validity of the
GALI-instrument [4,5] and on trends, socio-economic
or gender inequalities [13,14,16,20,21]. Additional, spe-
cial attention will be paid to provide easier access to
HLY information for the media, general public and
NGOs. EHLEIS (2007–2010) previously produced easy-
to-read material, such as an Interpreting Guide to HE,
as well as an annual 4-page Country report [1], a general
public website [22] and Wikipedia pages [23]. The
JA: EHLEIS will continue to develop similar readily
accessible material.
Methods
A first major aim of the Joint Action is to maintain and
continue developing the European Health and Life
Expectancy Information System (EHLEIS), by providing
online calculations of various health indicators (preva-
lence, LE, HEs including HLY) with confidence intervals,
that are comparable among EU countries, and with
improved dissemination, understanding, ease of access
and public health relevance. The methods and means to
meet this aim include: computational and web metho-
dologies for the EHLEIS database; statistical and demo-
graphic analyses for the substantive results; linguistic
methods for the translation/provision of the easy-to-use
web facilities in multiple European languages and trans-
lation of the Country reports into national languages;
and methodologies to address the conceptual basis of
the HLY indicator and its greater comparability with
Summary Measures of Population Health in the USA
and Japan. The JA: EHLEIS further develops the EHLEIS
system to allow rapid access to up-to-date data on health
expectancies (and the underlying health/disability preva-
lence and mortality data) from a variety of European
databases (SILC, Survey of Health, Ageing, and Retire-
ment in Europe (SHARE), EHIS). The computational
and web expertise to undertake this key foundation of
the Joint Action come from Montpellier RIO Imaging
[24]. Analysis and interpretation of data and computed
indicators are other important aims of the Joint Action.
Two work packages are totally devoted to these activi-
ties using a wide range of statistical methods at the
European, national, sub-national and individual level to
perform macro, micro or multi-level analyses, respec-
tively, with the aim to explain trends over time in life
and health expectancies (including HLY) and gaps
between Member States, genders and socio-economic
groups using amongst others health expectancy decom-
position tools [25]. Specific analyses will highlight factors
explaining limitations in usual activities and the origins
of the gaps. “What if” scenario analyses may help quanti-
fication of the impact on HLY of certain health
behaviour (for instance smoking) or public health inter-
ventions. The necessary statistical expertise is provided
by the EHLEIS associated partners (Belgium Scientific
Public Health Institute, French national institutes for
demographic studies (INED) and for health and medi-
cal research (INSERM), Erasmus MC, and Newcastle
University). Preparation for the next Summary Measure
of Population Health, the successor of the HLY, is the
second major aim of the Joint Action. To meet this
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objective the JA: EHLEIS organizes a series of seminars
with experts from the USA, Japan and other OECD
countries to agree on the conceptual basis for the new
Summary Measure of Population Health. The whole
Action is coordinated by the French National Institute
of Health and Medical Research INSERM.
Results and discussion
The main outcomes of the Joint Action will comprise:
(i) An Information System allowing online calculation
of health indicators (prevalence, life and health
expectancies (including HLY)), combining
population and mortality data with health
information coming from European
(SILC, SHARE, EHIS) and/or national surveys. All
HLY-related websites will be organized in a new
website [1];
(ii) Country reports on HE: Part of a series, each
annual report presents life expectancy and HLY for
the country of interest and for the overall EU27
using the SILC question on long term activity
limitation (GALI) included in the SILC survey
since 2004 or 2005. The reports will be translated
in the national languages and will be disseminated
to national institutions;
(iii) Proceedings of the JA: EHLEIS annual meetings:
The annual meetings will consist of one half-day
open to the public and media (back to back
with the Enlarged Steering Committee). The
main aim of the meeting is to encourage
Member States to use health expectancies,
including HLY, in their health, social and
employment policies;
(iv) Presentation of the new HLY values and latest
trends in Europe and press communiqués;
(v) Statistical tools - New version of attribution and
decomposition tools, distributed with updated
manuals through the website [1] and development
of impact assessment tool for HLY;
(vi) Technical reports and scientific analyses exploring
geographical variations in HLY within Europe,
trends in HEs in Europe, social differentials in HLY
across Member States and calibration of the Global
Activity Limitation Indicator (GALI) with EHIS
data;
(vii) A blueprint for a new international Summary
Measure of Population Health.
In addition the Joint Action plans to present its work
at major European Conferences such as the European
Health Forum in Gastein [26] and the EUPHA Confe-
rences [27].
Conclusion
The JA: EHLEIS contributes directly to two of the three
objectives of the Second Programme of Community Ac-
tion in the Field of Health 2008–2013: to promote health
and to generate and disseminate health information and
knowledge [18]. The JA: EHLEIS also contributes to the
Europe 2020 strategy and its innovation partnership on
active and healthy ageing with the target of increasing by
2 years the average number of healthy life years by 2020
[28]. The Joint Action not only offers the means to
monitor this headline target, it further contributes to-
wards identifying and understanding of the main deter-
minants of healthy life in Europe, thus offering new
avenues for policies targeting the expected increase in
HLY. As such the JA: EHLEIS is an important contribu-
tor to the 2012 European Year for Active Ageing and
Solidarity between Generations [29].
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